FDA Drops Biennial Inspection Requirement for Biologics

Drug Industry Daily
A A
The FDA issued a direct final rule removing the biennial inspection requirement for biologics production facilities and adopting a more flexible, risk-based approach to how often the agency will conduct inspections.

To View This Article:

Login

Subscribe To Drug Industry Daily